Immune Profiles in Metastatic Nasopharyngeal Cancer: A New Treatment Hope
Nasopharyngeal carcinoma (NPC) is linked to the Epstein-Barr virus (EBV). Immune checkpoint inhibitors (ICIs) are making waves in treating this cancer. When combined with chemotherapy, they're showing promise. This study dug into the immune cell profiles and how they affect survival in metastatic NP